These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 38545114)

  • 1. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.
    Ouyang P; Wang L; Wu J; Tian Y; Chen C; Li D; Yao Z; Chen R; Xiang G; Gong J; Bao Z
    Front Immunol; 2024; 15():1344272. PubMed ID: 38545114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for Gallium-67 SPECT in distinguishing progression and pseudoprogresion in oncologic patients receiving immunotherapy?
    Mauri D; Tsiouris S; Gkoura S; Gazouli I; Ntellas P; Amylidis A; Kampletsas L; Fotopoulos A
    Cancer Treat Res Commun; 2021; 28():100441. PubMed ID: 34404012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocktail strategy for 'cold' tumors therapy via active recruitment of CD8+ T cells and enhancing their function.
    Li X; Luo L; Jiang M; Zhu C; Shi Y; Zhang J; Qin B; Luo Z; Guo X; Lu Y; Shan X; Liu Y; Du Y; Ling P; You J
    J Control Release; 2021 Jun; 334():413-426. PubMed ID: 33964366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Firing up "cold" tumors: Ferroptosis causes immune activation by improving T cell infiltration.
    Li X; Li Y; Tuerxun H; Zhao Y; Liu X; Zhao Y
    Biomed Pharmacother; 2024 Oct; 179():117298. PubMed ID: 39151313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized patient-specific immune checkpoint inhibitor therapies for cancer treatment based on tumor immune microenvironment modeling.
    Yao Y; Chen YF; Zhang Q
    Brief Bioinform; 2024 Sep; 25(6):. PubMed ID: 39451158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turning cold tumors into hot tumors by improving T-cell infiltration.
    Liu YT; Sun ZJ
    Theranostics; 2021; 11(11):5365-5386. PubMed ID: 33859752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.
    McAuliffe J; Chan HF; Noblecourt L; Ramirez-Valdez RA; Pereira-Almeida V; Zhou Y; Pollock E; Cappuccini F; Redchenko I; Hill AV; Leung CSK; Van den Eynde BJ
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34479921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs).
    Rallis KS; Hillyar CRT; Sideris M; Davies JK
    Anticancer Res; 2021 Mar; 41(3):1123-1141. PubMed ID: 33788704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold Tumors: A Therapeutic Challenge for Immunotherapy.
    Bonaventura P; Shekarian T; Alcazer V; Valladeau-Guilemond J; Valsesia-Wittmann S; Amigorena S; Caux C; Depil S
    Front Immunol; 2019; 10():168. PubMed ID: 30800125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning cold tumors hot: from molecular mechanisms to clinical applications.
    Zhang J; Huang D; Saw PE; Song E
    Trends Immunol; 2022 Jul; 43(7):523-545. PubMed ID: 35624021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic tumor microenvironment modulators for turning cold tumors hot.
    Khosravi GR; Mostafavi S; Bastan S; Ebrahimi N; Gharibvand RS; Eskandari N
    Cancer Commun (Lond); 2024 May; 44(5):521-553. PubMed ID: 38551889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies to remodel immunologically cold tumors.
    Wang M; Wang S; Desai J; Trapani JA; Neeson PJ
    Clin Transl Immunology; 2020; 9(12):e1226. PubMed ID: 35136604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.
    Das S; Valton J; Duchateau P; Poirot L
    Front Immunol; 2023; 14():1172681. PubMed ID: 37251405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison.
    Cheng L; Chen L; Shi Y; Gu W; Ding W; Zheng X; Liu Y; Jiang J; Zheng Z
    Mol Cancer; 2024 Apr; 23(1):77. PubMed ID: 38627681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy.
    Benoit A; Vogin G; Duhem C; Berchem G; Janji B
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.
    Moreno-Vicente J; Willoughby JE; Taylor MC; Booth SG; English VL; Williams EL; Penfold CA; Mockridge CI; Inzhelevskaya T; Kim J; Chan HTC; Cragg MS; Gray JC; Beers SA
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
    Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation.
    Yuwen H; Wang H; Li T; Ren Y; Zhang YK; Chen P; Sun A; Bian G; Li B; Flowers D; Presler M; Subramanian K; Xue J; Wang J; Lynch K; Mei J; He X; Shan B; Hou B
    Cancer Res; 2024 May; 84(10):1680-1698. PubMed ID: 38501978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
    Wood GE; Meyer C; Petitprez F; D'Angelo SP
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.